Modelling of drug disposition kinetics in in vitro intestinal absorption cell models

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 3, 2010, Pages 180-188

  Heikkinen, Aki T ^a,b   Korjamo, Timo ^c   Mönkkönen, Jukka ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Biocenter Kuopio   (Finland)

^c Novamass Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL CULTURE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; COMPARTMENT MODEL; COMPUTER MODEL; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFERENCE PAPER; DRUG DISPOSITION; DRUG PENETRATION; DRUG TRANSPORT; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; MATHEMATICAL MODEL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 77149142588     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00504.x     Document Type: Conference Paper

References (51)

1. Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 1998 15 : 11 22.
2. Lennernäs H. Human intestinal permeability. J Pharm Sci 1998 87 : 403.
3. Matsson P, Bergstrom CA, Nagahara N, Tavelin S, Norinder U, Artursson P. Exploring the role of different drug transport routes in permeability screening. J Med Chem 2005 48 : 604 613.
4. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001 46 : 27 43. (Pubitemid 33653412)
5. Badhan R, Penny J, Galetin A, Houston JB. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption. J Pharm Sci 2009 98 : 2180 2197.
6. Balimane PV, Chong S. Cell culture-based models for intestinal permeability: a critique. Drug Discov Today 2005 10 : 335 343.
7. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001 299 : 620 628.
8. Fagerholm U. Prediction of human pharmacokinetics - gastrointestinal absorption. J Pharm Pharmacol 2007 59 : 905 916. (Pubitemid 47051070)
9. Hubatsch I, Ragnarsson EG, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc 2007 2 : 2111 2119.
10. Heikkinen AT, Mönkkönen J, Korjamo T. Kinetics of cellular retention during Caco-2 permeation experiments: role of lysosomal sequestration and impact on permeability estimates. J Pharmacol Exp Ther 2009 328 : 882 892.
11. Polli JE, Yu LX, Cook JA, Amidon GL, Borchardt RT, Burnside BA et al. Summary workshop report: biopharmaceutics classification system - implementation challenges and extension opportunities. J Pharm Sci 2004 93 : 1375 1381.
12. Palm K, Luthman K, Ros J, Gråsjö J, Artursson P. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J Pharmacol Exp Ther 1999 291 : 435 443.
13. Korjamo T, Heikkinen AT, Waltari P, Mönkkönen J. The asymmetry of the unstirred water layer in permeability experiments. Pharm Res 2008 25 : 1714 1722.
14. Tran TT, Mittal A, Gales T, Maleeff B, Aldinger T, Polli JW et al. Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier. J Pharm Sci 2004 93 : 2108 2123.
15. Thiel-Demby VE, Humphreys JE, St John Williams LA, Ellens HM, Shah N, Ayrton AD et al. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. Mol Pharm 2009 6 : 11 8.
16. Linnankoski J, Ranta VP, Yliperttula M, Urtti A. Passive oral drug absorption can be predicted more reliably by experimental than computational models - fact or myth. Eur J Pharm Sci 2008 34 : 129 139.
17. Englund G, Rorsman F, Ronnblom A, Karlbom U, Lazorova L, Gråsjö J et al. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 2006 29 : 269 277.
18. Bolger MB, Lukacova V, Woltosz WS. Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine. AAPS J 2009 11 : 353 363.
19. Berggren S, Gall C, Wollnitz N, Ekelund M, Karlbom U, Hoogstraate J et al. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol Pharm 2007 4 : 252 257.
20. Adson A, Burton PS, Raub TJ, Barsuhn CL, Audus KL, Ho NF. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci 1995 84 : 1197 1204.
21. Karlsson J, Artursson P. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int J Pharm 1991 71 : 55 64.
22. Korjamo T, Heikkinen AT, Mönkkönen J. Analysis of unstirred water layer in in vitro permeability experiments. J Pharm Sci 2009 98 : 4469 4479.
23. Avdeef A, Artursson P, Neuhoff S, Lazorova L, Gråsjö J, Tavelin S. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. Eur J Pharm Sci 2005 24 : 333 349.
24. Korjamo T, Kemilainen H, Heikkinen AT, Mönkkönen J. Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates. Drug Metab Dispos 2007 35 : 1574 1579.
25. Troutman MD, Thakker DR. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm Res 2003 20 : 1210 1224.
26. Neuhoff S, Ungell AL, Zamora I, Artursson P. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions. Pharm Res 2003 20 : 1141.
27. Kalvass JC, Pollack GM. Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition. Pharm Res 2007 24 : 265 276.
28. Del Amo EM, Heikkinen AT, Mönkkönen J. In vitro-in vivo correlation in p-glycoprotein mediated transport in intestinal absorption. Eur J Pharm Sci 2009 36 : 200 211.
29. Sun H, Pang KS. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study. Drug Metab Dispos 2008 36 : 102 123.
30. Troutman MD, Thakker DR. Efflux ratio cannot assess P-glycoprotein- mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm Res 2003 20 : 1200 1209.
31. Bentz J, Tran TT, Polli JW, Ayrton A, Ellens H. The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km. Pharm Res 2005 22 : 1667 1677.
32. Balakrishnan A, Hussainzada N, Gonzalez P, Bermejo M, Swaan PW, Polli JE. Bias in estimation of transporter kinetic parameters from overexpression systems: Interplay of transporter expression level and substrate affinity. J Pharmacol Exp Ther 2007 320 : 133 144.
33. Gonzalez-Alvarez I, Fernandez-Teruel C, Garrigues TM, Casabo VG, Ruiz-Garcia A, Bermejo M. Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM. Xenobiotica 2005 35 : 1067 1088.
34. Kapitza SB, Michel BR, van Hoogevest P, Leigh ML, Imanidis G. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model. Eur J Pharm Biopharm 2007 66 : 146 158.
35. Tran TT, Mittal A, Aldinger T, Polli JW, Ayrton A, Ellens H et al. The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. Biophys J 2005 88 : 715 738.
36. Tam D, Sun H, Pang KS. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis. Drug Metab Dispos 2003 31 : 1214 1226.
37. Zhang X, Shedden K, Rosania GR. A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. Mol Pharm 2006 3 : 704 716.
38. Sun H, Zhang L, Chow EC, Lin G, Zuo Z, Pang KS. A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: demonstration of substrate inhibition. J Pharmacol Exp Ther 2008 326 : 117 126.
39. Komin N, Toral R. Drug absorption through a cell monolayer: a theoretical work on a non-linear three-compartment model. European Journal of Pharmaceutical Sciences 2009 37 : 106 114.
40. Ito S, Woodland C, Sarkadi B, Hockmann G, Walker SE, Koren G. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. Am J Physiol 1999 277 : F84 96.
41. Lande MB, Donovan JM, Zeidel ML. The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons. J Gen Physiol 1995 106 : 67 84.
42. Bourdet DL, Pollack GM, Thakker DR. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells. Pharm Res 2006 23 : 1178 1187.
43. Lam TN, Hunt CA. Mechanistic simulations explain paradoxical saquinavir metabolism during in vitro vectorial transport study. Conf Proc IEEE Eng Med Biol Soc 2008 2008 : 5462 5465.
44. Liu Y, Hunt CA. Studies of intestinal drug transport using an in silico epithelio-mimetic device. BioSystems 2005 82 : 154 167.
45. Fisher J, Henzinger TA. Executable cell biology. Nat Biotechnol 2007 25 : 1239 1249.
46. Garmire LX, Hunt CA. In silico methods for unraveling the mechanistic complexities of intestinal absorption: metabolism-efflux transport interactions. Drug Metab Dispos 2008 36 : 1414 1424.
47. Huang W, Lee SL, Yu LX. Mechanistic Approaches to Predicting Oral Drug Absorption. AAPS J 2009 11 : 217 224.
48. Yu LX, Amidon GL. A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 1999 186 : 119 125.
49. Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan A et al. Population-based mechanistic prediction of oral drug absorption. AAPS J 2009 11 : 225 237.
50. Tubic M, Wagner D, Spahn-Langguth H, Bolger MB, Langguth P. In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect. Pharm Res 2006 23 : 1712 1720.
51. Jamei M, Dickinson GL, Rostami-Hodjegan A. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of 'bottom-up' vs 'top-down' recognition of covariates. Drug Metab Pharmacokinet 2009 24 : 53 75.